6676 Stock Overview
Sunny Pharmtech Inc. engages in the research, development, production, and sale of drug substances and products, and active pharmaceutical ingredients in Taiwan and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Sunny Pharmtech Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$29.60 |
52 Week High | NT$45.20 |
52 Week Low | NT$22.35 |
Beta | -0.055 |
1 Month Change | -6.92% |
3 Month Change | -14.94% |
1 Year Change | 27.86% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 25.69% |
Recent News & Updates
Recent updates
Shareholder Returns
6676 | TW Pharmaceuticals | TW Market | |
---|---|---|---|
7D | 1.7% | 1.7% | 1.1% |
1Y | 27.9% | 5.9% | 26.7% |
Return vs Industry: 6676 exceeded the TW Pharmaceuticals industry which returned 5.9% over the past year.
Return vs Market: 6676 exceeded the TW Market which returned 26.7% over the past year.
Price Volatility
6676 volatility | |
---|---|
6676 Average Weekly Movement | 4.5% |
Pharmaceuticals Industry Average Movement | 3.9% |
Market Average Movement | 4.2% |
10% most volatile stocks in TW Market | 7.9% |
10% least volatile stocks in TW Market | 1.9% |
Stable Share Price: 6676 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6676's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 129 | Yon-Lian Wu | https://www.sunnypharmtech.com |
Sunny Pharmtech Inc. engages in the research, development, production, and sale of drug substances and products, and active pharmaceutical ingredients in Taiwan and internationally. Its products portfolio include lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infection; aminocaproic acid tablets for blood diseases, as well as for hyper-proteolytic enzymes; and carboprost tromethamine injection for therapeutic abortion and postpartum hemorrhage. The company was founded in 1994 and is based in Taoyuan, Taiwan.
Sunny Pharmtech Inc. Fundamentals Summary
6676 fundamental statistics | |
---|---|
Market cap | NT$4.40b |
Earnings (TTM) | -NT$115.98m |
Revenue (TTM) | NT$381.56m |
11.5x
P/S Ratio-37.9x
P/E RatioIs 6676 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6676 income statement (TTM) | |
---|---|
Revenue | NT$381.56m |
Cost of Revenue | NT$120.15m |
Gross Profit | NT$261.41m |
Other Expenses | NT$377.39m |
Earnings | -NT$115.98m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.78 |
Gross Margin | 68.51% |
Net Profit Margin | -30.40% |
Debt/Equity Ratio | 59.6% |
How did 6676 perform over the long term?
See historical performance and comparison